GuiZhou SanLi Pharmaceutical Co.,Ltd (603439.SS)
CNY 13.79
(0.07%)
CNY 13.79
(0.07%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 175.72 Million CNY | 79.17% |
| 2022 | 98.07 Million CNY | 10.74% |
| 2021 | 88.56 Million CNY | 86.43% |
| 2020 | 47.5 Million CNY | -10.93% |
| 2019 | 53.34 Million CNY | 2.82% |
| 2018 | 51.87 Million CNY | 17.57% |
| 2017 | 44.12 Million CNY | -24.68% |
| 2016 | 58.58 Million CNY | -1.09% |
| 2015 | 59.22 Million CNY | 49.5% |
| 2014 | 39.61 Million CNY | 16.7% |
| 2013 | 33.94 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 314.5 Million CNY | 9.0% |
| 2024 Q2 | 288.55 Million CNY | 24.43% |
| 2024 Q1 | 231.89 Million CNY | 31.97% |
| 2023 Q3 | 131.56 Million CNY | -23.33% |
| 2023 Q2 | 171.58 Million CNY | 17.77% |
| 2023 Q1 | 145.69 Million CNY | 48.56% |
| 2023 FY | 175.72 Million CNY | 79.17% |
| 2023 Q4 | 175.72 Million CNY | 33.57% |
| 2022 FY | 98.07 Million CNY | 10.74% |
| 2022 Q4 | 98.07 Million CNY | -30.54% |
| 2022 Q3 | 141.18 Million CNY | 4.64% |
| 2022 Q2 | 134.92 Million CNY | 13.43% |
| 2022 Q1 | 118.94 Million CNY | 34.3% |
| 2021 Q2 | 52.99 Million CNY | -27.97% |
| 2021 Q1 | 73.57 Million CNY | 54.88% |
| 2021 FY | 88.56 Million CNY | 86.43% |
| 2021 Q3 | 84.12 Million CNY | 58.74% |
| 2021 Q4 | 88.56 Million CNY | 5.28% |
| 2020 Q4 | 47.5 Million CNY | -34.81% |
| 2020 Q1 | 75.57 Million CNY | 41.68% |
| 2020 FY | 47.5 Million CNY | -10.93% |
| 2020 Q2 | 62.83 Million CNY | -16.85% |
| 2020 Q3 | 72.88 Million CNY | 15.98% |
| 2019 Q4 | 53.34 Million CNY | 0.0% |
| 2019 Q2 | 73.18 Million CNY | 0.0% |
| 2019 FY | 53.34 Million CNY | 2.82% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 Q2 | 63.74 Million CNY | 10.7% |
| 2018 Q4 | 51.87 Million CNY | 0.0% |
| 2018 FY | 51.87 Million CNY | 17.57% |
| 2018 Q1 | 57.59 Million CNY | 30.52% |
| 2017 FY | 44.12 Million CNY | -24.68% |
| 2017 Q4 | 44.12 Million CNY | 0.0% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q3 | 44.12 Million CNY | 0.0% |
| 2016 Q1 | 75 Million CNY | 26.63% |
| 2016 Q3 | 58.58 Million CNY | -21.89% |
| 2016 FY | 58.58 Million CNY | -1.09% |
| 2016 Q2 | 75 Million CNY | 0.0% |
| 2016 Q4 | 58.58 Million CNY | 0.0% |
| 2015 Q2 | 52.83 Million CNY | 0.0% |
| 2015 Q4 | 59.22 Million CNY | 0.0% |
| 2015 Q3 | 59.22 Million CNY | 12.1% |
| 2015 FY | 59.22 Million CNY | 49.5% |
| 2015 Q1 | 52.83 Million CNY | 33.37% |
| 2014 Q3 | 39.61 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q4 | 39.61 Million CNY | 0.0% |
| 2014 FY | 39.61 Million CNY | 16.7% |
| 2013 FY | 33.94 Million CNY | 0.0% |